2 results · Page 1 of 1

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Study to Assess Safety and Tolerability of KarXT With Administration of Antiemetics in Healthy VolunteersNausea, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Signs and Symptoms, Digestive, VomitingRecruitingPhase 42026-09-18NCT07681076
MIST (Metabolic Intervention With Semaglutide and THR-β Therapy) TrialBody Weight, Nutritional and Metabolic Diseases, Overweight, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, nutritional disorder, obesity disorder, overnutritionActive, not recruitingPhase 22026-06-25NCT07505303